SI3131577T1 - Modificirane gostiljske celice in uporabe le-teh - Google Patents
Modificirane gostiljske celice in uporabe le-tehInfo
- Publication number
- SI3131577T1 SI3131577T1 SI201431611T SI201431611T SI3131577T1 SI 3131577 T1 SI3131577 T1 SI 3131577T1 SI 201431611 T SI201431611 T SI 201431611T SI 201431611 T SI201431611 T SI 201431611T SI 3131577 T1 SI3131577 T1 SI 3131577T1
- Authority
- SI
- Slovenia
- Prior art keywords
- host cells
- modified host
- modified
- cells
- host
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461980988P | 2014-04-17 | 2014-04-17 | |
PCT/EP2014/071898 WO2015158403A1 (en) | 2014-04-17 | 2014-10-13 | Modified host cells and uses thereof |
EP14784210.8A EP3131577B1 (en) | 2014-04-17 | 2014-10-13 | Modified host cells and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SI3131577T1 true SI3131577T1 (sl) | 2020-08-31 |
Family
ID=51726491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201431611T SI3131577T1 (sl) | 2014-04-17 | 2014-10-13 | Modificirane gostiljske celice in uporabe le-teh |
Country Status (17)
Country | Link |
---|---|
US (1) | US20170035900A1 (sl) |
EP (2) | EP3711776B1 (sl) |
JP (2) | JP6682451B2 (sl) |
CN (1) | CN106794237B (sl) |
BR (1) | BR112016023688B1 (sl) |
CA (1) | CA2945542C (sl) |
CY (1) | CY1123403T1 (sl) |
DK (1) | DK3131577T3 (sl) |
ES (2) | ES2939470T3 (sl) |
HR (1) | HRP20201021T1 (sl) |
HU (1) | HUE049806T2 (sl) |
LT (1) | LT3131577T (sl) |
MX (1) | MX2016013631A (sl) |
PL (1) | PL3131577T3 (sl) |
PT (1) | PT3131577T (sl) |
SI (1) | SI3131577T1 (sl) |
WO (1) | WO2015158403A1 (sl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201518668D0 (en) * | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Immunogenic Comosition |
CN105732818B (zh) * | 2016-03-02 | 2019-06-07 | 中国人民解放军第三军医大学 | 一种铜绿假单胞菌重组蛋白pop及其制备方法和应用 |
US11612647B2 (en) | 2017-06-23 | 2023-03-28 | University Of Maryland, Baltimore | Immunogenic compositions |
CA3104531A1 (en) * | 2018-06-27 | 2020-01-02 | Pivot Bio, Inc. | Guided microbial remodeling, a platform for the rational improvement of microbial species for agriculture |
CA3134216A1 (en) | 2019-03-18 | 2020-09-24 | Janssen Pharmaceuticals, Inc. | Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof |
CA3134045A1 (en) | 2019-03-18 | 2020-09-24 | Janssen Pharmaceuticals, Inc. | Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof |
CA3170889A1 (en) * | 2020-03-12 | 2021-09-16 | Christine Neupert | Vaccines comprising glycoengineered bacteria |
AU2021342797B2 (en) | 2020-09-17 | 2024-02-08 | Janssen Pharmaceuticals, Inc. | Multivalent vaccine compositions and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
ES2258214T3 (es) | 2002-03-07 | 2006-08-16 | Eidgenossische Technische Hochschule Zurich | Sistema y procedimiento para la produccion de proteinas glucosiladas recombinantes en un huesped procariotico. |
KR101524636B1 (ko) * | 2005-05-11 | 2015-06-03 | 에테하 취리히 | 원핵 세포로부터의 재조합 n-글리코실화 단백질 |
CA2646539A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Imidazoquinoxaline compounds as immunomodulators |
CA2646891A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
SI2257307T1 (sl) * | 2008-02-20 | 2018-09-28 | Glaxosmithkline Biologicals S.A. | Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic |
PT2501406T (pt) * | 2009-11-19 | 2018-02-21 | Glaxosmithkline Biologicals Sa | Sistema de biossíntese que produz polissacáridos imunogénicos em células procariotas |
ES2844596T3 (es) * | 2010-05-06 | 2021-07-22 | Glaxosmithkline Biologicals Sa | Vacunas de bioconjugados de bacterias grampositivas capsulares |
JP2014526449A (ja) * | 2011-09-06 | 2014-10-06 | グリコヴァキシン アーゲー | 原核細胞において製造されるバイオコンジュゲートワクチン |
BR112015004817A2 (pt) * | 2012-09-10 | 2017-07-04 | Glycovaxyn Ag | bioconjugados compreendendo antígenos modificados e seus usos |
EP3527663B1 (en) * | 2012-10-12 | 2021-12-01 | GlaxoSmithKline Biologicals SA | Methods of host cell modification |
JP6412875B2 (ja) * | 2012-11-07 | 2018-10-24 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
EA201690529A1 (ru) * | 2013-10-11 | 2016-11-30 | Гликоваксин Аг | Способы модификации клетки-хозяина |
-
2014
- 2014-10-13 WO PCT/EP2014/071898 patent/WO2015158403A1/en active Application Filing
- 2014-10-13 ES ES20170090T patent/ES2939470T3/es active Active
- 2014-10-13 LT LTEP14784210.8T patent/LT3131577T/lt unknown
- 2014-10-13 EP EP20170090.3A patent/EP3711776B1/en active Active
- 2014-10-13 ES ES14784210T patent/ES2805000T3/es active Active
- 2014-10-13 PT PT147842108T patent/PT3131577T/pt unknown
- 2014-10-13 EP EP14784210.8A patent/EP3131577B1/en active Active
- 2014-10-13 DK DK14784210.8T patent/DK3131577T3/da active
- 2014-10-13 JP JP2016562754A patent/JP6682451B2/ja active Active
- 2014-10-13 HU HUE14784210A patent/HUE049806T2/hu unknown
- 2014-10-13 CA CA2945542A patent/CA2945542C/en active Active
- 2014-10-13 BR BR112016023688-2A patent/BR112016023688B1/pt active IP Right Grant
- 2014-10-13 US US15/304,557 patent/US20170035900A1/en not_active Abandoned
- 2014-10-13 SI SI201431611T patent/SI3131577T1/sl unknown
- 2014-10-13 MX MX2016013631A patent/MX2016013631A/es unknown
- 2014-10-13 CN CN201480079804.3A patent/CN106794237B/zh active Active
- 2014-10-13 PL PL14784210T patent/PL3131577T3/pl unknown
-
2020
- 2020-03-25 JP JP2020053544A patent/JP2020114232A/ja active Pending
- 2020-06-29 HR HRP20201021TT patent/HRP20201021T1/hr unknown
- 2020-07-09 CY CY20201100633T patent/CY1123403T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN106794237A (zh) | 2017-05-31 |
EP3131577B1 (en) | 2020-04-22 |
HRP20201021T1 (hr) | 2020-10-16 |
CY1123403T1 (el) | 2022-03-24 |
JP2017513480A (ja) | 2017-06-01 |
HUE049806T2 (hu) | 2020-10-28 |
ES2939470T3 (es) | 2023-04-24 |
PT3131577T (pt) | 2020-07-17 |
JP6682451B2 (ja) | 2020-04-15 |
DK3131577T3 (da) | 2020-07-13 |
US20170035900A1 (en) | 2017-02-09 |
LT3131577T (lt) | 2020-07-27 |
JP2020114232A (ja) | 2020-07-30 |
EP3131577A1 (en) | 2017-02-22 |
WO2015158403A1 (en) | 2015-10-22 |
BR112016023688A2 (pt) | 2018-01-30 |
CA2945542A1 (en) | 2015-10-22 |
CN106794237B (zh) | 2022-04-12 |
MX2016013631A (es) | 2017-02-28 |
PL3131577T3 (pl) | 2020-10-19 |
EP3711776B1 (en) | 2023-01-11 |
EP3711776A1 (en) | 2020-09-23 |
CA2945542C (en) | 2024-03-05 |
ES2805000T3 (es) | 2021-02-10 |
BR112016023688B1 (pt) | 2024-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1243332A1 (zh) | 改變在修飾的t細胞中的基因表達及其用途 | |
HK1231471A1 (zh) | -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途 | |
IL247344B (en) | A new polysaccharide and its uses | |
IL252216B (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
SG11201609118RA (en) | Modified natural killer cells and uses thereof | |
IL246755A0 (en) | The heteroaryls and their use | |
HUE044571T2 (hu) | Módosított ciklopentapeptidek és alkalmazásaik | |
HK1231555A1 (zh) | 生物標誌物及其用途 | |
HUE049806T2 (hu) | Módosított gazdasejtek és alkalmazásaik | |
SG11201704473WA (en) | New methods and uses | |
HK1243077A1 (zh) | 呱啶基吡唑並嘧啶酮及其用途 | |
SG11201610514SA (en) | Bioreactor and uses thereof | |
GB201408091D0 (en) | Methods and uses | |
GB201622225D0 (en) | Modified host cells and uses thereof | |
GB201419897D0 (en) | Host cell | |
PL3229772T3 (pl) | 6-arylo-9-glikozylopuryny i ich zastosowanie | |
EP3233107A4 (en) | Nbp158 and uses thereof | |
GB201416086D0 (en) | Methods and uses | |
GB201416073D0 (en) | Methods and uses | |
AU2014901390A0 (en) | Immune cell markers and uses thereof | |
AU2014901388A0 (en) | Immune cell markers and uses thereof | |
AU2014901389A0 (en) | Immune cell markers and uses thereof | |
AU2014904616A0 (en) | Biomarkers and uses thereof | |
GB201415379D0 (en) | Gamma T cells and uses thereof | |
GB201407419D0 (en) | Conductive materials and uses thereof |